European Medicines Agency Investigation On January 17, 2025, the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee launched a review of semaglutide medications such as Ozempic and Wegovy due to the increased risk of developing NAION
Exercise is restricted, diet is controlled and medication advised to all to manage the typical symptoms of the disease
For summer 2027 you apply in fall 2026, roughly 89 months before the May start, which is tight by pharma standards
This eye cream texture is the best I have tried
A preliminary report from another study claimed a mild benefit of 3 to 8 grams of thiamin per day in DAT, but no additional data from that study are available (69)
NICE NG28 similarly recommends considering periodic monitoring of B12 in people at risk on long-term metformin this is not a blanket recommendation for all metformin users, but is targeted at those with relevant risk factors or symptoms